Abdoli Shadbad, Mahdi, Amir Baghbanzadeh, and Behzad Baradaran. 2024. “Hsa-MiR-34a-5p Enhances Temozolomide Anti-Tumoral Effects on Glioblastoma: In-Silico and in-Vitro Study”. EXCLI Journal 23 (March):384-400. https://doi.org/10.17179/excli2023-6404.